Bilateral chronic subdural hematoma cases showing rapid and progressive aggravation

Kurokawa, Y; Ishizaki, Eri; Inaba, Kenichi

doi:10.1016/j.surneu.2004.12.030

Cited by 38 publications

(27 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These included separated type, bilateral, skull base involvement of CSDH and MHD (Table II). The impacts of bilateral CSDHs, separated type CSDH and CSDH with skull base involvement on recurrence have previously been reported as important prognostic factors for CSDHs [9,12,13,17,18], thereby corroborating previous findings [14]. The current study, however, is unique in its identification of MHD as a significant factor closely associated with the recurrence of CSDH.…”

Section: Univariate Analysis For Post-operative Recurrencesupporting

confidence: 88%

“…The tendency toward re-bleeding depends on the balance between coagulative and fibrinolytic activities. Furthermore, according to Kurokawa et al [17], mixed high and low intensity signals in T2WI or low intensity signals in T1WI are the most reliable predictive factors in revealing the rapid aggravation of bilateral CSDHs. These clinical findings and qualitative analysis prompt analytical quantification.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Quantitative assessment of post-operative recurrence of chronic subdural haematoma using mean haematoma density

Lin

Chen

et al. 2014

Brain Injury

View full text Add to dashboard Cite

show abstract

Section: Univariate Analysis For Post-operative Recurrencesupporting

confidence: 88%

Section: Discussionmentioning

confidence: 99%

Quantitative assessment of post-operative recurrence of chronic subdural haematoma using mean haematoma density

Lin

Chen

et al. 2014

Brain Injury

View full text Add to dashboard Cite

show abstract

“…One report showed that neurological deterioration occurred rapidly (within 19-54 hours), even if patients with bilateral CSDH had minimal or no neurological deficits at the time of initial diagnosis or at the time of admission (11). According to this study, the rapid increase and symptomatic aggravation of bilateral hematoma might be associated with recurrence.…”

Section: Bilateral Csdhmentioning

confidence: 50%

“…In previous studies, several risk factors for recurrence of CSDH have been reported, including advanced age, bleeding tendency, brain atrophy, alcohol abuse, bilateral CSDH, hematoma density, DM, arachnoid cyst, postoperative posture, postoperative subdural air accumulation, inflammatory cytokines, and some technical aspects of surgery (1,3,7,8,11,13,15,16,24). Our goal in this study was to identify risk factors for the recurrence of CSDH using a multivariate analysis with a logistic regression model.…”

Section: Discussionmentioning

confidence: 99%

Independent Predictors for Recurrence of Chronic Subdural Hematoma

et al. 2008

View full text Add to dashboard Cite

show abstract

“…It is still unclear that a hematoma location is associated with CSDH recurrence. Kurokawa et al 9) concluded that the bilateral CSDH should be treated as early as possible with bilateral decompression of hematoma pressure, even if the patients showed no or minor neurological deficits.…”

Section: Related Factors For Recurrencementioning

confidence: 99%

One vs. Two Burr Hole Craniostomy in Surgical Treatment of Chronic Subdural Hematoma

Han

Park

Kim

et al. 2009

J Korean Neurosurg Soc

View full text Add to dashboard Cite

Objective : Chronic subdural hematoma (CSDH) is one of the most common types of traumatic intracranial hemorrhage, usually occurring in the older patients, with a good surgical prognosis. Burr hole craniostomy is the most frequently used neurosurgical treatment of CSDH. However, there have been only few studies to assess the role of the number of burr holes in respect to recurrence rates. The aim of this study is to compare the postoperative recurrence rates between one and two burr craniostomy with closed-system drainage for CSDH. Methods : From January 2002 to December 2006, 180 consecutive patients who were treated with burr hole craniostomy with closed-system drainage for the symptomatic CSDH were enrolled. Pre-and post-operative computed tomography (CT) scans and/or magnetic resonance imaging (MRI) were used for radiological evaluation. The number of burr hole was decided by neurosurgeon's preference and was usually made on the maximum width of hematoma. The patients were followed with clinical symptoms or signs and CT scans. All the drainage catheters were maintained below the head level and removed after CT scans showing satisfactory evacuation. All patients were followed-up for at least 1 month after discharge. Results : Out of 180 patients, 51 patients were treated with one burr hole, whereas 129 were treated with two burr holes. The overall postoperative recurrence rate was 5.6% (n = 10/180) in our study. One of 51 patients (2.0%) operated on with one burr hole recurred, whereas 9 of 129 patients (7.0%) evacuated by two burr holes recurred. Although the number of burr hole in this study is not statistically associated with postoperative recurrence rate (p > 0.05), CSDH treated with two burr holes showed somewhat higher recurrence rates. Conclusion :In agreement with previous studies, burr hole craniostomy with closed drainage achieved a good surgical prognosis as a treatment of CSDH in this study. Results of our study indicate that burr hole craniostomy with one burr hole would be sufficient to evacuate CSDH with lower recurrence rate.

show abstract

Bilateral chronic subdural hematoma cases showing rapid and progressive aggravation

Cited by 38 publications

References 8 publications

Quantitative assessment of post-operative recurrence of chronic subdural haematoma using mean haematoma density

Quantitative assessment of post-operative recurrence of chronic subdural haematoma using mean haematoma density

Independent Predictors for Recurrence of Chronic Subdural Hematoma

One vs. Two Burr Hole Craniostomy in Surgical Treatment of Chronic Subdural Hematoma

Contact Info

Product

Resources

About